Update on emerging infections: News from the centers for disease control and prevention

Annals of Emergency Medicine

Volumn 40, Issue 1, 2002, Pages 115-119

  Karras, David J ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PERTUSSIS VACCINE;

DISEASE CONTROL; EMERGENCY HEALTH SERVICE; EMERGENCY MEDICINE; HEALTH PROGRAM; HUMAN; INFECTION; INFECTION CONTROL; INFECTION PREVENTION; MEDICAL INFORMATION SYSTEM; PERTUSSIS; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW;

EID: 0036630886     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1067/mem.2002.125448     Document Type: Article

References (22)

1. Epidemiologic features of pertussis in the United States, 1980-1989
2. Pertussis vaccination: Use of acellular pertussis vaccines among infants and young children. Recommendations of the Advisory Committee on Immunization Practices (ACIP)
3. Design and estimation for the National Health Interview Survey, 1995-2004
4. National Immunization Survey: The methodology of a vaccination surveillance system
5. Estimation of vaccine effectiveness using the screening method
6. Changing epidemiology of pertussis in the United States: Increasing reported incidence among adolescents and adults, 1990-1996
7. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989-1998
8. Increasing incidence of pertussis among young infants in the United States, 1980-98
9. Effectiveness of the Pertussis Vaccination Program as determined by use of the screening method: United States, 1992-1994
10. Bordetella species
11. Long term respiratory sequelae of whooping cough in a nationally representative sample
12. Epidemiological features of pertussis in the United States, 1980-1989
13. Pertussis infection in adults with persistent cough
14. Prevalence and incidence of adult pertussis in an urban population
15. Prevalence of positive serology for acute Chlamydia pneumoniae infection in emergency department patients with persistent cough
16. Recommendations for use of the polymerase chain reaction in diagnosis of B pertussis infections
17. Erythromycin study group: Comparison of erythromycin estolate and erythromycin ethylsuccinate for treatment of pertussis
18. Erythromycin in the treatment of pertussis: A study of bacteriologic and clinical effects
19. Seven days of erythromycin estolate is as effective as 14 days for treatment of B pertussis infections
20. Prevention of secondary transmission of pertussis in households with early use of erythromycin
21. Recommended childhood immunization schedule - United States, January-December 2000